Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4636 AL 4650

Building a roadmap for developing combination therapies for Alzheimer's disease

Perry D, Sperling R, Katz R, Berry D, Dilts D, Hanna D, Salloway S, Trojanowski JQ, Bountra C, Krams M, Luthman J, Potkin S, Gribkoff V, Temple R, Wang Y, Carrillo MC, Stephenson D, Snyder H, Liu E, Ware T, McKew J, Fields FO, Bain LJ, Bens C.

Expert Rev Neurother. 2015 Mar;15(3):327-33. doi: 10.1586/14737175.2015.996551.

Neurostimulation in Alzheimer's disease: from basic research to clinical applications

Nardone R, Höller Y, Tezzon F, Christova M, Schwenker K, Golaszewski S, Trinka E, Brigo F.

Neurol Sci. 2015 May;36(5):689-700. doi: 10.1007/s10072-015-2120-6. Epub 2015 Feb 27.

Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease

Peter C, Braidy N, Zarka M, Welch J, Bridge W.

Curr Alzheimer Res. 2015;12(4):298-313. doi: 10.2174/1567205012666150302160308.

Vanutide cridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer's disease: results from two phase 2 studies

Arai H, Suzuki H, Yoshiyama T.

Curr Alzheimer Res. 2015;12(3):242-54. doi: 10.2174/1567205012666150302154121.

Increased libido associated with donepezil treatment: a case report

Segrec N, Zaman R, Pregelj P.

Psychogeriatrics. 2016 Jan;16(1):70-2. doi: 10.1111/psyg.12113. Epub 2015 Mar 3.

Growth factor treatment to overcome Alzheimer's dysfunctional signaling

Lauzon MA, Daviau A, Marcos B, Faucheux N.

Cell Signal. 2015 Jun;27(6):1025-38. doi: 10.1016/j.cellsig.2015.02.018. Epub 2015 Mar 3.

Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways

Bohm C, Chen F, Sevalle J, Qamar S, Dodd R, Li Y, Schmitt-Ulms G, Fraser PE, St George-Hyslop PH.

Mol Cell Neurosci. 2015 May;66(Pt A):3-11. doi: 10.1016/j.mcn.2015.02.016. Epub 2015 Mar 4.

Emerging drug targets for Aβ and tau in Alzheimer's disease: a systematic review

West S, Bhugra P.

Br J Clin Pharmacol. 2015 Aug;80(2):221-34. doi: 10.1111/bcp.12621. Epub 2015 Jun 8.

Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives

Tong LM, Fong H, Huang Y.

Exp Mol Med. 2015 Mar 13;47(3):e151. doi: 10.1038/emm.2014.124.

β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis

Francioso A, Punzi P, Boffi A, Lori C, Martire S, Giordano C, D'Erme M, Mosca L.

Bioorg Med Chem. 2015 Apr 15;23(8):1671-83. doi: 10.1016/j.bmc.2015.02.041. Epub 2015 Feb 28.

Do We Try Mending Humpty Dumpty or Prevent His Fall? An Alzheimer's Disease Dilemma

de la Torre Jack C.

J Alzheimers Dis. 2015;46(2):289-96. doi: 10.3233/JAD-150124.

First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study

Andreasen N, Simeoni M, Ostlund H, Lisjo PI, Fladby T, Loercher AE, Byrne GJ, Murray F, Scott-Stevens PT, Wallin A, Zhang YY, Bronge LH, Zetterberg H, Nordberg AK, Yeo AJ, Khan SA, Hilpert J, Mistry PC.

PLoS One. 2015 Mar 19;10(3):e0098153. doi: 10.1371/journal.pone.0098153. eCollection 2015.

[Mindfulness-based stimulation in advanced Alzheimer's disease: A comparative, non-inferiority, clinical pilot study]

Quintana Hernández DJ, Miró Barrachina MT, Ibáñez Fernández I, Santana del Pino A, Rojas Hernández J, Rodríguez García J, Quintana Montesdeoca Mdel P.

Rev Esp Geriatr Gerontol. 2015 Jul-Aug;50(4):168-73. doi: 10.1016/j.regg.2014.11.010. Epub 2015 Mar 18.

Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease

Lauzon MA, Daviau A, Marcos B, Faucheux N.

J Control Release. 2015 May 28;206:187-205. doi: 10.1016/j.jconrel.2015.03.024. Epub 2015 Mar 22.

EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

Schmidt R, Hofer E, Bouwman FH, Buerger K, Cordonnier C, Fladby T, Galimberti D, Georges J, Heneka MT, Hort J, Laczó J, Molinuevo JL, O'Brien JT, Religa D, Scheltens P, Schott JM, Sorbi S.

Eur J Neurol. 2015 Jun;22(6):889-98. doi: 10.1111/ene.12707. Epub 2015 Mar 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias